WCN26-2066 INTRADIALYTIC KINETICS OF CARDIAC BIOMARKERS DURING HIGH-FLUX HEMODIALYSIS AND POST-DILUTION HEMODIAFILTRATION: A RANDOMIZED CROSSOVER TRIAL

Read full text Summarise with VIRAT
Authors: Caroline Hundborg Liboriussen, Louis B. Nygaard, Gertrud Dam-Dalgeir, Rie Io Glerup, Allan Thøyer Stang Birnum, Jens Dam Jensen, My Svensson
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cardiovascular disease (CVD) is a major cause of mortality in patients treated with hemodialysis (HD). Furthermore, diagnosing CVD in this population presents several challenges, which include atypical or absent symptoms of myocardial infarction (MI), a high presence of elevated troponin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, and limited data on how dialysis treatment affects cardiac biomarker concentrations. The aim of this study was to investigate the intradialytic kinetics of high-sensitivity cardiac troponin I and T (hs-cTnI and hs-cTnT) and NT-proBNP during HD and hemodiafiltration (HDF).

Fields of Study & Subjects

Dialysis and Renal Disease Management Heart Failure Treatment and Management Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105182–105182
Publication date
25 March 2026
Language
EN